SCHEMBL5776864

SCHEMBL5776864

CCOC(=O)c1cnoc1-c1ccc(OC)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.51
POLB P06746 1/20 0.51
TARBP2 Q15633 2/20 0.51
PDCD4 Q53EL6 1/20 0.51
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
NPC1 O15118 2/20 0.48
MAPT P10636 2/20 0.48
RAB9A P51151 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773388 0.87 TARBP2 (0.48) GAATARBP2MEN1KMT2ANPC1
SCHEMBL20507202 0.86 ALDH1A1 (0.57) POLBMEN1KMT2ANPC1MAPT
SCHEMBL5773089 0.86 DHODH (0.46) POLBNPC1MAPTRAB9ALMNA
SCHEMBL11384351 0.85 ALDH1A1 (0.48) GAAMEN1KMT2ANPC1MAPT
SCHEMBL5771735 0.85 ALDH1A1 (0.50) GAAPOLBTARBP2MEN1KMT2A
SCHEMBL343836 0.85 HTT (0.50) TARBP2MEN1KMT2ANPC1MAPT
SCHEMBL10668171 0.85 SMN1; SMN2 (0.52) POLBTARBP2NPC1MAPTRAB9A
SCHEMBL11382098 0.85 ALDH1A1 (0.57) GAAMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL6502372 0.85 TSHR (0.53) GAAPOLBMEN1KMT2ANPC1
SCHEMBL5774456 0.83 HTT (0.59) GAAMEN1KMT2ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed
US-4243406-A REDUCING INJURIES TO CROP PLANTS WHEN USING AN ALPHA-HALOACETANILIDE AS A HERBICIDE MONSANTO COMPANY (US) 1981-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR GAA 2207/4885POLB 3996/4885TARBP2 4614/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 GAA 1930/4885POLB 3909/4885TARBP2 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.